Thoughts and suggestions on giving full play to the role of traditional Chinese medicine in bolstering China’s public health and emergency response system_West China Medical Journal

Authors：

YAO Jianhong ¹ ,  FAN Yugai ² , LIU Zhiyong ³ , ZENG Zhi ^4,5

1. Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P. R. China;
2. Medical Insurance Office, Guang’anmen Hospital, China Academy of Traditional Chinese Medicine, Beijing 100053, P. R. China;
3. School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P. R. China;
4. Healthcare Reform Department, Chongqing Municipal Health Commission, Chongqing 401147, P. R. China;
5. Institute of Hospital Management, West China School of Medicine / West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

FAN Yugai, Email: 2636478703@qq.com

Keywords：

Public health; Emergency management system; Traditional Chinese medicine

DOI：

10.7507/1002-0179.202103109

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The traditional Chinese medicine has played an important role in the prevention and control of coronavirus disease 2019 (COVID-19). Based on the role of traditional Chinese medicine in dealing with the previous epidemics and COVID-19, this paper analyzes the problems and challenges of current situation, and focuses on improving traditional Chinese medicine scientific identification, strengthening the construction of traditional Chinese medicine system, and increasing the intensity of Chinese and Western medicine and so on. In order to improve the cooperation mechanism of Chinese and Western medicine for epidemic prevention and control, and give full play to the role of traditional Chinese medicine in the construction of national public health emergency system, this paper also gives ten corresponding suggestions.

Citation： YAO Jianhong, FAN Yugai, LIU Zhiyong, ZENG Zhi. Thoughts and suggestions on giving full play to the role of traditional Chinese medicine in bolstering China’s public health and emergency response system. West China Medical Journal, 2021, 36(6): 731-735. doi: 10.7507/1002-0179.202103109 Copy

1.	张彩霞. 发挥中医药在新发传染病防控中的重要作用. 中国卫生法制, 2020, 28(6): 80-86.
2.	解瑞峰, 张英, 徐世友. 中医药在防治传染性非典型肺炎中的应用. 职业与健康, 2005, 21(3): 436.
3.	朱君华, 丁刚强. 甲型 H1N1 流感疫情综述. 浙江中医药大学学报, 2009, 33(3): 299-301.
4.	Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
5.	中华人民共和国国务院新闻办公室. 中国的中医药. 北京: 人民出版社, 2016.
6.	杜松, 于峥, 赵凯维, 等. 中医药防治重大疫情应急管理体系研究现状及对策建议. 中国中医基础医学杂志, 2020, 26(7): 1009-1012.
7.	中华人民共和国国务院新闻办公室. 国新办举行中医药防治新冠肺炎重要作用及有效药物发布会. (2020-03-23)[2021-03-10]. http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42768/wz42770/Document/1675777/1675777.htm.
8.	中华人民共和国中央人民政府. 关于印发新型冠状病毒感染的肺炎诊疗方案（试行第三版）的通知. (2020-01-22)[2021-05-25]. http://www.gov.cn/zhengce/zhengceku/2020-01/23/content_5471832.htm.
9.	余艳红, 于文明. 充分发挥中医药独特优势和作用为人民群众健康作出新贡献. 中国中西医结合杂志, 2020, 40(9): 1029-1031.
10.	余艳红. 发挥中医药独特优势和作用构建强大的公共卫生体系. 人民周刊, 2020(18): 69-70.
11.	陈曦. 以疗效为支点, 中医药抗疫经验走向国际战场. 科技日报. 10.28502/n.cnki.nkjrb.2020.001477.
12.	中国新闻网. 广东中医药抗疫物资驰援智利和伊朗. (2020-04-07)[2021-02-22]. http://www.chinanews.com/hr/2020/04-07/9150146.shtml.
13.	喻小勇, 田侃. 论中医药融入国家公共卫生应急管理体系. 南京中医药大学学报(社会科学版), 2020, 21(2): 145-150.
14.	苏芮, 郭玉红, 刘清泉. 中医药应急能力建设现状及相关政策研究. 中国中医急症, 2019, 28(9): 1665-1668.
15.	王君平. 《中华人民共和国中医药法》实施3周年: 为中医药创新性发展提供法治保障. 中国中西医结合杂志, 2020, 40(7): 890.
16.	Ni X, Chen Y, Du L, et al. Evidence-based Chinese medicine for the response to public health emergencies: the Guangzhou declaration. J Evid Based Med, 2021, 14(1): 3-4.
17.	高路. 中英公共卫生应急体系比较与经验借鉴. 中外医学研究, 2011, 9(12): 93-96.
18.	中共中央党史和文献研究院. 习近平关于统筹疫情防控和经济社会发展重要论述选编. 北京: 中央文献出版社, 2020.

1. 张彩霞. 发挥中医药在新发传染病防控中的重要作用. 中国卫生法制, 2020, 28(6): 80-86.
2. 解瑞峰, 张英, 徐世友. 中医药在防治传染性非典型肺炎中的应用. 职业与健康, 2005, 21(3): 436.
3. 朱君华, 丁刚强. 甲型 H1N1 流感疫情综述. 浙江中医药大学学报, 2009, 33(3): 299-301.
4. Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
5. 中华人民共和国国务院新闻办公室. 中国的中医药. 北京: 人民出版社, 2016.
6. 杜松, 于峥, 赵凯维, 等. 中医药防治重大疫情应急管理体系研究现状及对策建议. 中国中医基础医学杂志, 2020, 26(7): 1009-1012.
7. 中华人民共和国国务院新闻办公室. 国新办举行中医药防治新冠肺炎重要作用及有效药物发布会. (2020-03-23)[2021-03-10]. http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42768/wz42770/Document/1675777/1675777.htm.
8. 中华人民共和国中央人民政府. 关于印发新型冠状病毒感染的肺炎诊疗方案（试行第三版）的通知. (2020-01-22)[2021-05-25]. http://www.gov.cn/zhengce/zhengceku/2020-01/23/content_5471832.htm.
9. 余艳红, 于文明. 充分发挥中医药独特优势和作用为人民群众健康作出新贡献. 中国中西医结合杂志, 2020, 40(9): 1029-1031.
10. 余艳红. 发挥中医药独特优势和作用构建强大的公共卫生体系. 人民周刊, 2020(18): 69-70.
11. 陈曦. 以疗效为支点, 中医药抗疫经验走向国际战场. 科技日报. 10.28502/n.cnki.nkjrb.2020.001477.
12. 中国新闻网. 广东中医药抗疫物资驰援智利和伊朗. (2020-04-07)[2021-02-22]. http://www.chinanews.com/hr/2020/04-07/9150146.shtml.
13. 喻小勇, 田侃. 论中医药融入国家公共卫生应急管理体系. 南京中医药大学学报(社会科学版), 2020, 21(2): 145-150.
14. 苏芮, 郭玉红, 刘清泉. 中医药应急能力建设现状及相关政策研究. 中国中医急症, 2019, 28(9): 1665-1668.
15. 王君平. 《中华人民共和国中医药法》实施3周年: 为中医药创新性发展提供法治保障. 中国中西医结合杂志, 2020, 40(7): 890.
16. Ni X, Chen Y, Du L, et al. Evidence-based Chinese medicine for the response to public health emergencies: the Guangzhou declaration. J Evid Based Med, 2021, 14(1): 3-4.
17. 高路. 中英公共卫生应急体系比较与经验借鉴. 中外医学研究, 2011, 9(12): 93-96.
18. 中共中央党史和文献研究院. 习近平关于统筹疫情防控和经济社会发展重要论述选编. 北京: 中央文献出版社, 2020.

West China Medical Journal

Thoughts and suggestions on giving full play to the role of traditional Chinese medicine in bolstering China’s public health and emergency response system

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content